GT Biopharma (GTBP) Total Debt (2010 - 2021)
GT Biopharma (GTBP) posted quarterly Total Debt of $31000.0 for Q4 2021, down 99.88% year-over-year from $26.3 million in Q4 2020, and little changed quarter-over-quarter from $31000.0 in Q3 2021.
GT Biopharma (GTBP) Total Debt (2010 - 2021) Analysis & Trends
GT Biopharma (GTBP) has reported Total Debt for 12 consecutive years, with $31000.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Total Debt fell 99.88% year-over-year to $31000.0; the TTM figure through Dec 2021 stood at $31000.0 (down 99.88% YoY), while the FY2021 annual figure was $31000.0, down 99.88% from the prior year.
- Total Debt was little changed at $31000.0 in Q4 2021 per GTBP's latest filing, from $31000.0 in the prior quarter.
- Across five years, Total Debt topped out at $26.3 million in Q4 2020 and bottomed at $31000.0 in Q3 2017.
- Historically, Total Debt has averaged $8.4 million across 5 years, with a median of $8.8 million in 2018.
- Annual changes were most pronounced in 2018 — Total Debt jumped 34429.03% — and 2021, when it tumbled 99.88%.
- GT Biopharma's Total Debt stood at $31000.0 in 2017, then surged by 34429.03% to $10.7 million in 2018, then gained by 23.67% to $13.2 million in 2019, then surged by 98.93% to $26.3 million in 2020, then sank by 99.88% to $31000.0 in 2021.
- Business Quant data shows GTBP's Total Debt at $31000.0 in Q4 2021, $31000.0 in Q3 2021, and $31000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | GT Biopharma | 8.38 Mn | 8.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 31,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Jun 30, 2021 | 31,000.00 |
| Mar 31, 2021 | 31,000.00 |
| Dec 31, 2020 | 26.33 Mn |
| Sep 30, 2020 | 23.03 Mn |
| Jun 30, 2020 | 21.88 Mn |
| Mar 31, 2020 | 13.29 Mn |
| Dec 31, 2019 | 13.24 Mn |
| Sep 30, 2019 | 13.17 Mn |
| Jun 30, 2019 | 12.20 Mn |
| Mar 31, 2019 | 11.33 Mn |
| Dec 31, 2018 | 10.70 Mn |
| Sep 30, 2018 | 10.63 Mn |
| Jun 30, 2018 | 6.89 Mn |
| Mar 31, 2018 | 2.96 Mn |
| Dec 31, 2017 | 31,000.00 |
| Sep 30, 2017 | 31,000.00 |
| Jun 30, 2017 | 875,000.00 |
| Mar 31, 2017 | 875,000.00 |